Welcome to our dedicated page for Progress Oh SEC filings (Ticker: PGR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Progressive Corporation filings document formal disclosures for an Ohio-based insurance holding company with common shares listed on the New York Stock Exchange. Its 8-K reports regularly furnish monthly and year-to-date operating results for the company and its consolidated subsidiaries, including net premiums written, net premiums earned, net income, per-share results, combined ratio, realized securities gains or losses, and policies in force by line of business.
The filing record also includes capital-structure disclosures tied to senior notes and material agreements, proxy materials covering board governance, shareholder voting matters, executive compensation, and equity awards, and officer-transition disclosures under current-report requirements.
Form 144 filed for Progressive Corporation (PGR) reports a proposed sale of 1,345 shares of Common stock through Fidelity Brokerage Services, with an aggregate market value of $337,299.10 and an approximate sale date of 08/22/2025 on the NYSE. The filing states these shares were acquired through restricted stock vesting on 07/25/2025 and were issued as compensation. The filer previously sold three separate blocks of Common shares in the past three months—each of 1,267 shares—generating gross proceeds of $351,985.27, $329,901.46 and $313,633.18 on 05/23/2025, 06/20/2025 and 07/18/2025 respectively. The notice includes the standard signed representation that the seller is unaware of undisclosed material adverse information.
The Progressive Corporation filed a current report stating that it issued a news release with financial results for the month and year-to-date periods ended July 31, 2025. The release, dated August 20, 2025, covers the performance of the company and its consolidated subsidiaries.
The news release is furnished under a Regulation FD disclosure item and attached as Exhibit 99, giving investors access to updated monthly and year-to-date financial information in a single document.
Lori A. Niederst, CRM President at Progressive Corporation (PGR), reported an insider sale on 08/14/2025 under a 10b5-1 trading plan. The filing shows 8,063 shares sold at $250.18 per share. After the reported sale, the reporting person beneficially owns 39,040.497 shares directly and 196.81 shares indirectly through a spouse's 401(k) plan. The 10b5-1 plan was adopted on March 28, 2025. The Form 4 was signed by an attorney-in-fact on 08/15/2025.
Progressive Corporation (PGR) Form 144 reports a proposed sale of 5,329 common shares held at Fidelity Brokerage Services LLC with an aggregate market value of $1,333,209.22. The filing states these shares were acquired by restricted stock vesting from the issuer on 07/25/2025 and the approximate sale date is 08/14/2025.
The notice identifies the sale as compensation-related and shows no securities sold by the reporting person in the past three months. The filer certifies they are unaware of any undisclosed material adverse information about the issuer.
Progressive Corporation (PGR): Rule 144 notice of proposed sale. The filing reports an intended sale of 8,063 common shares held at Fidelity Brokerage Services with an aggregate market value of $2,017,201.34 based on the filing. The securities were acquired on 07/25/2025 through restricted stock vesting from the issuer and were paid as compensation. The filer reports no securities sold in the past three months. The approximate sale date listed is 08/14/2025 on the NYSE. Several issuer and filer identification fields (names, CIK, contact details) are not provided in the visible content.
Progressive (PGR) Q2-25 10-Q highlights: Net premiums earned rose 18% YoY to $20.3 bn; total revenue advanced 21% to $22.0 bn, boosted by a 26% gain in investment income and a swing to $387 m net realized gains.
Losses & LAE increased 8% to $13.6 bn, but expense growth (11%) lagged revenue, lifting PBT 114% to $4.0 bn. Net income more than doubled to $3.2 bn; diluted EPS climbed to $5.40 from $2.48.
Six-month view: revenue $42.4 bn (+20%), net income $5.7 bn (+52%), EPS $9.77. Operating cash flow improved 22% to $9.2 bn.
Balance sheet: Investments expanded to $88.6 bn (+23% YoY); shareholders’ equity jumped 40% to $32.6 bn as net unrealized losses on fixed maturities narrowed to $-81 m (vs. $-1.7 bn). Debt steady at $6.9 bn; book value ≈ $55.6/share.
Capital actions: $2.75 bn common dividends and $78 m buybacks YTD; no preferred dividends post Series B redemption (Feb-24).
Takeaways: robust premium growth, higher investment yield and favorable capital markets drove record profitability, while claims costs and sizable dividend outflows remain watch-points.